[144] Houlihan Lokey, Inc. SEC Filing

Rhea-AI Filing Summary

Houlihan Lokey (HLI) submitted a Form 144 notifying the proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,997,848.00 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock vesting under a registered plan: 20,016 shares vested on 05/15/2023 and 19,984 shares vested on 05/15/2024, with payment described as services rendered. The filer reports no sales in the past three months and affirms no undisclosed material adverse information.

Positive

• None.

Negative

• Planned sale of 40,000 common shares representing an aggregate market value of $7,997,848.00 scheduled for 08/27/2025
• Insufficient filer identity/relationship details in the provided content, limiting ability to assess insider status or governance implications

Insights

Securities Analyst

TL;DR Officer/affiliate intends to sell 40,000 vested restricted shares valued near $8.0M; routine Rule 144 notice, limited immediate informational impact.

This Form 144 documents a planned Rule 144 sale of restricted shares that vested under a registered plan. The filing shows the shares were acquired via compensation (services rendered) in two vesting events in 2023 and 2024. The sale is routed through Morgan Stanley Smith Barney on the NYSE and is scheduled for 08/27/2025. The filing contains no disclosure of insider identity or additional context about motivation. For investors, the filing confirms an insider liquidity event but does not by itself indicate operational or financial deterioration.

Corporate Governance Expert

TL;DR This is a compliance disclosure of a planned insider sale under Rule 144; governance implications are routine absent further details.

The Form 144 satisfies regulatory requirements by reporting the number of shares, acquisition dates, nature of acquisition (restricted stock vesting), broker details, and the approximate sale date. The statement that there were no securities sold in the past three months and the signer27s attestation regarding material non-public information are standard. Because the filing omits the filer27s name/relationship in the provided content, stakeholders cannot assess insider status or evaluate potential governance signaling beyond the sale itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	40000	7997848.00	54369453	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2023	Restricted stock vesting under a registered plan	Issuer			20016	05/15/2023	Services Rendered
Common	05/15/2024	Restricted stock vesting under a registered plan	Issuer			19984	05/15/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for HLI disclose?

The filing discloses a proposed sale of 40,000 HLI common shares through Morgan Stanley Smith Barney, aggregate value $7,997,848.00, approx. sale date 08/27/2025.

How were the HLI shares to be sold acquired?

The shares were acquired as restricted stock vesting under a registered plan: 20,016 vested on 05/15/2023 and 19,984 vested on 05/15/2024, consideration listed as services rendered.

Did the filer report any HLI sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker and exchange are involved in the proposed HLI sale?

The broker is Morgan Stanley Smith Barney LLC and the planned transaction is listed for the NYSE.

Does the Form 144 assert the filer possesses undisclosed material information?

The filer represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.